Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Jain

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 18, 2021
Preliminary outcomes reported from three randomized controlled trials of CD19 CAR-T cell therapies in large B cell lymphomaMichael D Jain
Transplantation and Cellular Therapy|March 30, 2025
Prolonged Neurologic Symptoms After CAR T Cell Therapy - What Is It?Michael D Jain
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 15, 2013
Methemoglobinemia from curing saltMichael D Jain, Anna Nikonova
Drugs|August 19, 2017
Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin LymphomaMichael D Jain, John Kuruvilla
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2021
Seeing the Light: CAR T-cell Targeting of Lambda-restricted B-cell LymphomasMichael D Jain, Frederick L Locke
Stem Cells (Dayton, Ohio)|October 13, 2017
Concise Review: Emerging Principles from the Clinical Application of Chimeric Antigen Receptor T Cell Therapies for B Cell MalignanciesMichael D Jain, Marco L Davila
Blood|September 11, 2025
Immune dysfunction after cancer remission: scar or disease?Michael D Jain, Jonathan Cools-Lartigue
Clinical Advances in Hematology & Oncology : H&O|October 10, 2018
Advances in aggressive lymphoma from the 2018 American Society of Clinical Oncology annual meeting: commentaryFrederick L Locke, Michael D Jain
Ejhaem|July 18, 2022
Imagining the cell therapist: Future CAR T cell monitoring and intervention strategies to improve patient outcomesMichael D Jain, Jay Y Spiegel
Transplantation and Cellular Therapy|April 19, 2023
Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple MyelomaKai Rejeski, Michael D Jain, Eric L Smith
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 18, 2021
Preliminary outcomes reported from three randomized controlled trials of CD19 CAR-T cell therapies in large B cell lymphomaMichael D Jain
Transplantation and Cellular Therapy|March 30, 2025
Prolonged Neurologic Symptoms After CAR T Cell Therapy - What Is It?Michael D Jain
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 15, 2013
Methemoglobinemia from curing saltMichael D Jain, Anna Nikonova
Drugs|August 19, 2017
Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin LymphomaMichael D Jain, John Kuruvilla
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2021
Seeing the Light: CAR T-cell Targeting of Lambda-restricted B-cell LymphomasMichael D Jain, Frederick L Locke
Stem Cells (Dayton, Ohio)|October 13, 2017
Concise Review: Emerging Principles from the Clinical Application of Chimeric Antigen Receptor T Cell Therapies for B Cell MalignanciesMichael D Jain, Marco L Davila
Blood|September 11, 2025
Immune dysfunction after cancer remission: scar or disease?Michael D Jain, Jonathan Cools-Lartigue
Clinical Advances in Hematology & Oncology : H&O|October 10, 2018
Advances in aggressive lymphoma from the 2018 American Society of Clinical Oncology annual meeting: commentaryFrederick L Locke, Michael D Jain
Ejhaem|July 18, 2022
Imagining the cell therapist: Future CAR T cell monitoring and intervention strategies to improve patient outcomesMichael D Jain, Jay Y Spiegel
Transplantation and Cellular Therapy|April 19, 2023
Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple MyelomaKai Rejeski, Michael D Jain, Eric L Smith
Pageof 11